Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hyun Ae Jung

Showing results (1-10 of 144) with videos related to

Pageof 15
Sort By:
The Korean Journal of Internal Medicine|October 22, 2020
Mutations in genes affecting DNA methylation enhances responses to decitabine in patients with myelodysplastic syndromeHyun Ae Jung, Chul Won Jung, Jun Ho Jang
Annals of Laboratory Medicine|February 6, 2018
Clinical Utility of a Diagnostic Approach to Detect Genetic Abnormalities in Multiple Myeloma: A Single Institution ExperienceHyun Ae Jung, Mi Ae Jang, Kihyun Kim, et al.
Cancer Immunology, Immunotherapy : CII|October 30, 2020
Nivolumab for esophageal squamous cell carcinoma and the predictive role of PD-L1 or CD8 expression in its therapeutic effectJiyun Lee, Binnari Kim, Hyun Ae Jung, et al.
JAMA Oncology|September 25, 2025
Emerging EGFR-Targeted Therapy in Head and Neck Cancer: A ReviewWoochan Hwang, Jong Seok Ahn, Hyun Ae Jung, et al.
Chemotherapy|December 5, 2014
Treatment Outcome and Relevance of Palliative Chemotherapy in Urachal CancerHyun Ae Jung, Jong-Mu Sun, Se Hoon Park, et al.
Scientific Reports|June 25, 2024
Comparative effectiveness of lazertinib in patients with EGFR T790M-positive non-small-cell lung cancer using a real-world external controlHa-Lim Jeon, Meesong Kwak, Sohee Kim, et al.
Oncotarget|May 5, 2015
Platelet response during the second cycle of decitabine treatment predicts response and survival for myelodysplastic syndrome patientsHyun Ae Jung, Chi Hoon Maeng, Moonjin Kim, et al.
Lung Cancer (Amsterdam, Netherlands)|June 12, 2020
Ten-year patient journey of stage III non-small cell lung cancer patients: A single-center, observational, retrospective study in Korea (Realtime autOmatically updated data warehOuse in healTh care; UNIVERSE-ROOT study)Hyun Ae Jung, Jong-Mu Sun, Se-Hoon Lee, et al.
Translational Lung Cancer Research|October 19, 2023
Real-world clinical evidence of lazertinib use in acquired <i>EGFR</i> T790M mutated non-small cell lung cancerSehhoon Park, Hyun Ae Jung, Se-Hoon Lee, et al.
Cancer Research and Treatment|January 3, 2023
The Role of Brain Radiotherapy before First-Line Afatinib Therapy, Compared to Gefitinib or Erlotinib, in Patients with EGFR-Mutant Non-Small Cell Lung CancerHyun Ae Jung, Sehhoon Park, Se-Hoon Lee, et al.
Pageof 15

Showing results (1-10 of 144) with videos related to

Sort By:
Pageof 15
The Korean Journal of Internal Medicine|October 22, 2020
Mutations in genes affecting DNA methylation enhances responses to decitabine in patients with myelodysplastic syndromeHyun Ae Jung, Chul Won Jung, Jun Ho Jang
Annals of Laboratory Medicine|February 6, 2018
Clinical Utility of a Diagnostic Approach to Detect Genetic Abnormalities in Multiple Myeloma: A Single Institution ExperienceHyun Ae Jung, Mi Ae Jang, Kihyun Kim, et al.
Cancer Immunology, Immunotherapy : CII|October 30, 2020
Nivolumab for esophageal squamous cell carcinoma and the predictive role of PD-L1 or CD8 expression in its therapeutic effectJiyun Lee, Binnari Kim, Hyun Ae Jung, et al.
JAMA Oncology|September 25, 2025
Emerging EGFR-Targeted Therapy in Head and Neck Cancer: A ReviewWoochan Hwang, Jong Seok Ahn, Hyun Ae Jung, et al.
Chemotherapy|December 5, 2014
Treatment Outcome and Relevance of Palliative Chemotherapy in Urachal CancerHyun Ae Jung, Jong-Mu Sun, Se Hoon Park, et al.
Scientific Reports|June 25, 2024
Comparative effectiveness of lazertinib in patients with EGFR T790M-positive non-small-cell lung cancer using a real-world external controlHa-Lim Jeon, Meesong Kwak, Sohee Kim, et al.
Oncotarget|May 5, 2015
Platelet response during the second cycle of decitabine treatment predicts response and survival for myelodysplastic syndrome patientsHyun Ae Jung, Chi Hoon Maeng, Moonjin Kim, et al.
Lung Cancer (Amsterdam, Netherlands)|June 12, 2020
Ten-year patient journey of stage III non-small cell lung cancer patients: A single-center, observational, retrospective study in Korea (Realtime autOmatically updated data warehOuse in healTh care; UNIVERSE-ROOT study)Hyun Ae Jung, Jong-Mu Sun, Se-Hoon Lee, et al.
Translational Lung Cancer Research|October 19, 2023
Real-world clinical evidence of lazertinib use in acquired <i>EGFR</i> T790M mutated non-small cell lung cancerSehhoon Park, Hyun Ae Jung, Se-Hoon Lee, et al.
Cancer Research and Treatment|January 3, 2023
The Role of Brain Radiotherapy before First-Line Afatinib Therapy, Compared to Gefitinib or Erlotinib, in Patients with EGFR-Mutant Non-Small Cell Lung CancerHyun Ae Jung, Sehhoon Park, Se-Hoon Lee, et al.
Pageof 15